Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 10:21:40 UTC
Update Date2021-09-26 23:05:04 UTC
HMDB IDHMDB0252469
Secondary Accession NumbersNone
Metabolite Identification
Common NameFostamatinib
DescriptionFostamatinib, also known as R 788 compound or tavalisse, belongs to the class of organic compounds known as methoxyanilines. These are organic compound containing an aniline group substituted at one or more positions by a methoxy group. Based on a literature review a significant number of articles have been published on Fostamatinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Fostamatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Fostamatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
R 788 CompoundMeSH
R788 CompoundMeSH
TavalisseMeSH
R788 FREE acidChEMBL
R-788R-935788R935788 FREE acidChEMBL
{[6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}imino)-2,2-dimethyl-3-oxo-2H,3H,4H,5H,6H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxy}phosphonateGenerator
Chemical FormulaC23H26FN6O9P
Average Molecular Weight580.4595
Monoisotopic Molecular Weight580.148291177
IUPAC Name{[6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}imino)-2,2-dimethyl-3-oxo-2H,3H,4H,5H,6H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxy}phosphonic acid
Traditional Name[6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}imino)-2,2-dimethyl-3-oxo-5H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxyphosphonic acid
CAS Registry NumberNot Available
SMILES
COC1=CC(NC2=NC=C(F)C(N=C3NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
InChI Identifier
InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)
InChI KeyGKDRMWXFWHEQQT-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as methoxyanilines. These are organic compound containing an aniline group substituted at one or more positions by a methoxy group.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassAniline and substituted anilines
Direct ParentMethoxyanilines
Alternative Parents
Substituents
  • Methoxyaniline
  • Anisole
  • Phenol ether
  • Methoxybenzene
  • Phenoxy compound
  • Halopyrimidine
  • Aminopyridine
  • Aminopyrimidine
  • Monoalkyl phosphate
  • Alkyl aryl ether
  • Organic phosphoric acid derivative
  • Aryl halide
  • Imidolactam
  • Alkyl phosphate
  • Pyrimidine
  • Pyridine
  • Phosphoric acid ester
  • Aryl fluoride
  • Heteroaromatic compound
  • Tertiary carboxylic acid amide
  • Lactam
  • Carboxamide group
  • Azacycle
  • Carboxylic acid derivative
  • Ether
  • Oxacycle
  • Organoheterocyclic compound
  • Organic nitrogen compound
  • Organohalogen compound
  • Organofluoride
  • Carbonyl group
  • Organonitrogen compound
  • Organooxygen compound
  • Amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.62ALOGPS
logP2.03ChemAxon
logS-3.8ALOGPS
pKa (Strongest Acidic)1.45ChemAxon
pKa (Strongest Basic)3.53ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count13ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area186.19 ŲChemAxon
Rotatable Bond Count9ChemAxon
Refractivity150.35 m³·mol⁻¹ChemAxon
Polarizability54.3 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+220.33630932474
DeepCCS[M-H]-217.9430932474
DeepCCS[M-2H]-250.92730932474
DeepCCS[M+Na]+227.15330932474
AllCCS[M+H]+227.332859911
AllCCS[M+H-H2O]+225.932859911
AllCCS[M+NH4]+228.532859911
AllCCS[M+Na]+228.932859911
AllCCS[M-H]-223.632859911
AllCCS[M+Na-2H]-224.932859911
AllCCS[M+HCOO]-226.632859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
FostamatinibCOC1=CC(NC2=NC=C(F)C(N=C3NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC5596.2Standard polar33892256
FostamatinibCOC1=CC(NC2=NC=C(F)C(N=C3NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC3979.3Standard non polar33892256
FostamatinibCOC1=CC(NC2=NC=C(F)C(N=C3NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC4716.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Fostamatinib,1TMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC4227.0Semi standard non polar33892256
Fostamatinib,1TMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC4278.0Standard non polar33892256
Fostamatinib,1TMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC6778.2Standard polar33892256
Fostamatinib,1TMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC4119.3Semi standard non polar33892256
Fostamatinib,1TMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC4312.9Standard non polar33892256
Fostamatinib,1TMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC7082.2Standard polar33892256
Fostamatinib,1TMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC4253.4Semi standard non polar33892256
Fostamatinib,1TMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC4282.2Standard non polar33892256
Fostamatinib,1TMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC7252.1Standard polar33892256
Fostamatinib,2TMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC4192.4Semi standard non polar33892256
Fostamatinib,2TMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC4239.7Standard non polar33892256
Fostamatinib,2TMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC6166.2Standard polar33892256
Fostamatinib,2TMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC4107.2Semi standard non polar33892256
Fostamatinib,2TMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC4171.8Standard non polar33892256
Fostamatinib,2TMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC6286.4Standard polar33892256
Fostamatinib,2TMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC4253.5Semi standard non polar33892256
Fostamatinib,2TMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC4160.4Standard non polar33892256
Fostamatinib,2TMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC6427.1Standard polar33892256
Fostamatinib,2TMS,isomer #4COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC4148.4Semi standard non polar33892256
Fostamatinib,2TMS,isomer #4COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC4208.7Standard non polar33892256
Fostamatinib,2TMS,isomer #4COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC6625.3Standard polar33892256
Fostamatinib,3TMS,isomer #1COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC4109.5Semi standard non polar33892256
Fostamatinib,3TMS,isomer #1COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC4090.7Standard non polar33892256
Fostamatinib,3TMS,isomer #1COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C)=CC(OC)=C1OC5716.6Standard polar33892256
Fostamatinib,3TMS,isomer #2COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC4232.1Semi standard non polar33892256
Fostamatinib,3TMS,isomer #2COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC4093.9Standard non polar33892256
Fostamatinib,3TMS,isomer #2COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)=CC(OC)=C1OC5855.0Standard polar33892256
Fostamatinib,3TMS,isomer #3COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC4150.1Semi standard non polar33892256
Fostamatinib,3TMS,isomer #3COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC4045.4Standard non polar33892256
Fostamatinib,3TMS,isomer #3COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC5906.0Standard polar33892256
Fostamatinib,4TMS,isomer #1COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC4153.9Semi standard non polar33892256
Fostamatinib,4TMS,isomer #1COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC3954.5Standard non polar33892256
Fostamatinib,4TMS,isomer #1COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C)=N2)[Si](C)(C)C)=CC(OC)=C1OC5375.7Standard polar33892256
Fostamatinib,1TBDMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC4409.1Semi standard non polar33892256
Fostamatinib,1TBDMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC4490.4Standard non polar33892256
Fostamatinib,1TBDMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC6830.7Standard polar33892256
Fostamatinib,1TBDMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4299.5Semi standard non polar33892256
Fostamatinib,1TBDMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4501.8Standard non polar33892256
Fostamatinib,1TBDMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC6966.9Standard polar33892256
Fostamatinib,1TBDMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC4432.9Semi standard non polar33892256
Fostamatinib,1TBDMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC4495.9Standard non polar33892256
Fostamatinib,1TBDMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC7088.9Standard polar33892256
Fostamatinib,2TBDMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC4518.5Semi standard non polar33892256
Fostamatinib,2TBDMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC4582.2Standard non polar33892256
Fostamatinib,2TBDMS,isomer #1COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)=CC(OC)=C1OC6285.7Standard polar33892256
Fostamatinib,2TBDMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4433.5Semi standard non polar33892256
Fostamatinib,2TBDMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4509.7Standard non polar33892256
Fostamatinib,2TBDMS,isomer #2COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C([NH]3)N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC6260.2Standard polar33892256
Fostamatinib,2TBDMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC4593.7Semi standard non polar33892256
Fostamatinib,2TBDMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC4530.5Standard non polar33892256
Fostamatinib,2TBDMS,isomer #3COC1=CC(NC2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O[Si](C)(C)C(C)(C)C)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)=CC(OC)=C1OC6374.7Standard polar33892256
Fostamatinib,2TBDMS,isomer #4COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4504.3Semi standard non polar33892256
Fostamatinib,2TBDMS,isomer #4COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC4516.6Standard non polar33892256
Fostamatinib,2TBDMS,isomer #4COC1=CC(N(C2=NC=C(F)C(N=C3C=CC4=C(N(COP(=O)(O)O)C(=O)C(C)(C)O4)N3[Si](C)(C)C(C)(C)C)=N2)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC6419.2Standard polar33892256
Spectra

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 10V, Positive-QTOFsplash10-001i-0000090000-23ebd85a5d96bfbc3b522017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 20V, Positive-QTOFsplash10-001i-1000090000-3b740a34def25351a64c2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 40V, Positive-QTOFsplash10-0ff9-0629000000-0c74cf7aa278957933312017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 10V, Negative-QTOFsplash10-004i-2000090000-a3ba42e7f8da38830e4b2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 20V, Negative-QTOFsplash10-004i-9100030000-9288838ff51180fdbe942017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 40V, Negative-QTOFsplash10-004i-9202000000-6539073d24303037811e2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 10V, Positive-QTOFsplash10-001i-0000390000-8740c8917271dd768c562021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 20V, Positive-QTOFsplash10-001i-0000960000-a31a696e8e64e70fc4a02021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 40V, Positive-QTOFsplash10-014i-1002900000-bcd930f0b928b30d9de52021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 10V, Negative-QTOFsplash10-004i-0000090000-28edb9aed79aae34d26a2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 20V, Negative-QTOFsplash10-004i-9000000000-ca30e71e114ea66730882021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Fostamatinib 40V, Negative-QTOFsplash10-004i-9000100000-39c315332c306234c8872021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB12010
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9846198
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkFostamatinib
METLIN IDNot Available
PubChem Compound11671467
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]